in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—30 April
April 30, 2013 | Deepti Ramesh
Lonza results in line with expectations Lonza, in its business update announcement for the first quarter of 2013, says that its business performance was solid and in line with expectations. “Earlier this year, we announced significant changes to our organization, aligning ourselves directly with markets we serve. The newly focused organization is taking hold while delivering on our first-quarter results,” says Richard Ridinger, CEO of Lonza. “At the same time, we are working broadly to assess the performance and efficiencies across of our...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee